Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
WRN
REST API REST API
Homo sapiens
WRN is differentially expressed in 206 experiments: 103 organism parts: bone marrow, mammary gland, ... (101 more);, 150 disease states: normal, chronic myelogenous leukemia, ... (148 more);, 59 cell types 261 cell lines 24 compound treatments and 57 other conditions.
Synonyms RECQ3, RECQL2
Orthologs SGS1 (Saccharomyces cerevisiae)   ENSCING00000008935 (Ciona intestinalis)   WRN (Gallus gallus)   wrn (Danio rerio)   WRN (Bos taurus)   Wrn (Mus musculus)   RecQ4 (Drosophila melanogaster)   F1LTH9_RAT (Rattus norvegicus)   wrn (Xenopus laevis)   Q5SBI9_CANFA (Canis familiaris)   (Compare orthologs)
Gene Ontology Term telomere maintenance, response to oxidative stress, DNA binding, 3'-5' DNA helicase activity, protein binding, DNA repair, cellular metabolic process, intracellular, 3'-5' exonuclease activity, ATPase activity, ATP-dependent helicase activity, nucleic acid binding, multicellular organismal aging, ATP-dependent 3'-5' DNA helicase activity, four-way junction helicase activity, ATP binding, magnesium ion binding, centrosome, Y-form DNA binding, nucleus, ATP-dependent DNA helicase activity, manganese ion binding, aging, DNA recombination, nucleotide binding, DNA helicase activity, protein homodimerization activity, nucleoplasm, base-excision repair, response to DNA damage stimulus, DNA synthesis involved in DNA repair, exonuclease activity, DNA replication, nucleolus, helicase activity, DNA metabolic process, regulation of apoptosis, G-quadruplex DNA binding, cell aging, replication fork processing, ATP catabolic process, MutLalpha complex, response to UV-C, regulation of growth rate, positive regulation of hydrolase activity, bubble DNA binding, nucleolus to nucleoplasm transport, protein complex binding, cellular response to starvation, replicative cell aging, nucleobase-containing compound metabolic process
InterPro Term Helicase/RNaseD_C, DNA/RNA_helicase_DEAD/DEAH_N, RQC_domain, Helicase_C, DNA_helicase_ATP-dep_RecQ, DEAD-like_helicase, 3'-5'_exonuclease
UniProt Accession Q14191
Gene-Disease Assocation WERNER SYNDROME; WRN, COLORECTAL CANCER; CRC
Search EB-eye ENSG00000165392
Show more properties
Experimental Factors
Organism part

studied in E-AFMX-5, E-GEOD-6573, E-MEXP-1251, E-MTAB-24, E-MEXP-433, ... (19 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-GEOD-17482, E-GEOD-5258, E-GEOD-4525, E-GEOD-19639, E-GEOD-18005, ... (29 experiments)

Factor Value U/D Experiments
MCF7
2
E-MTAB-37, E-GEOD-5258
HL-60
2
E-MTAB-37, E-GEOD-24147
MCF-7
2
E-GEOD-19639, E-GEOD-20081
NA18501
1
E-GEOD-19480
SW403
1
E-MTAB-37
DKMG
1
E-MTAB-37
255 more value(s).


Cell type

studied in E-GEOD-20193, E-GEOD-3920, E-MEXP-750, E-GEOD-4219, E-GEOD-20677, ... (39 experiments)

Factor Value U/D Experiments
CD105+ endothelial
2
E-AFMX-5, E-TABM-145
memory B cell
1
2
E-MEXP-2360, E-TABM-702, E-GEOD-17186
wild_type
1
E-GEOD-20193
CXCR4 negative
1
E-GEOD-15893
CD34+CD38-/lowCD19+ cell
1
E-MEXP-1403
naive T cell
1
E-GEOD-1460
53 more value(s).


Disease state

studied in E-GEOD-3307, E-GEOD-2466, E-GEOD-1577, E-GEOD-9692, E-MTAB-62, ... (37 experiments)

Factor Value U/D Experiments
uterine fibroid
2
E-MTAB-62, E-GEOD-7307
control
2
E-GEOD-21912, E-GEOD-8121
ischemic cardiomyopathy
1
E-MTAB-62
KSHV infection
1
E-MEXP-66
Ischemia
1
E-MTAB-62
Emery-Dreifuss muscular dystrophy
1
E-MTAB-62
144 more value(s).


Compound treatment

studied in E-GEOD-5258, E-GEOD-6907, E-GEOD-1417, E-GEOD-697, E-TABM-782, ... (15 experiments)

Factor Value U/D Experiments
none
3
4
E-TABM-782, E-GEOD-5824, E-MEXP-1601, E-GEOD-412, E-GEOD-995, ... (7 experiments)
5-aza-2'-deoxycytidine + trichostatin A
1
1
E-MEXP-1269
U0126
1
E-GEOD-697
lipopolysaccharide
1
E-GEOD-3720
unknown
1
E-GEOD-7307
HMB-PP (phosphoantigen)
1
E-MEXP-1601
18 more value(s).


Agent

studied in E-GEOD-19519

Factor Value U/D Experiments
thapsigargin
1
E-GEOD-19519
tunicamycin
1
E-GEOD-19519


BioSourceProvider
studied in E-GEOD-19519, E-GEOD-19480

Blood/non-blood meta-groups
studied in E-MTAB-62

Cancer site
studied in E-GEOD-4271

cd34
studied in E-GEOD-22601

Cell treatment
studied in E-MEXP-1192

Cellular component
studied in E-GEOD-1400

Clinical history
studied in E-GEOD-22097, E-TABM-234, E-GEOD-19743, E-GEOD-7967, E-GEOD-21589, ... (7 experiments)

Clinical info
studied in E-GEOD-19743, E-MTAB-37, E-GEOD-22513, E-MEXP-1251, E-GEOD-21589, ... (6 experiments)

Clinical treatment
studied in E-GEOD-6532

coriell cell line repository identifier
studied in E-GEOD-19519

Developmental stage
studied in E-GEOD-20033, E-GEOD-3140, E-MEXP-2359, E-GEOD-2666, E-MTAB-62 ... (5 experiments)

Disease staging
studied in E-GEOD-19743, E-GEOD-7788, E-GEOD-3325, E-TABM-147, E-GEOD-21138, ... (6 experiments)

double amplification
studied in E-GEOD-22601

Environmental stress
studied in E-GEOD-1643, E-GEOD-1518, E-GEOD-3720

Estrogen receptor status
studied in E-GEOD-6532

Ethnic group
studied in E-GEOD-20194, E-GEOD-16716

family id
studied in E-GEOD-19519

Genetic modification
studied in E-GEOD-8023, E-MEXP-1482, E-GEOD-20847

Genotype
studied in E-GEOD-2466, E-TABM-321, E-GEOD-18005, E-TABM-601, E-GEOD-1153, ... (9 experiments)

369 groups
studied in E-MTAB-62

4 groups from blood to incompletely diff
studied in E-MTAB-62

96 groups
studied in E-MTAB-62

Growth condition
studied in E-TABM-263, E-GEOD-13073, E-MEXP-1220, E-MEXP-2657, E-GEOD-20504, ... (7 experiments)

Her2 fish
studied in E-GEOD-20194, E-GEOD-16716

Histology
studied in E-TABM-234, E-TABM-276

Individual
studied in E-MTAB-197, E-TABM-325, E-GEOD-2466, E-GEOD-1926, E-MEXP-2069, ... (29 experiments)

Infection
studied in E-MEXP-1274, E-GEOD-2405, E-GEOD-6802

Injury
studied in E-GEOD-19743

Lymph node status
studied in E-GEOD-6532

Material type
studied in E-MEXP-455

Media
studied in E-MEXP-765

15 meta groups
studied in E-MTAB-62

4 meta groups
studied in E-MTAB-62

6 meta groups
studied in E-MTAB-62

Metastasis
studied in E-GEOD-18105

Molecular subtype
studied in E-GEOD-21653

organ
studied in E-GEOD-24283

Organism
studied in E-GEOD-7540, E-TABM-84

Phenotype
studied in E-GEOD-21750, E-MEXP-1403

Population
studied in E-GEOD-4342

Progesterone receptor status
studied in E-GEOD-6532

Protocol type
studied in E-GEOD-22097, E-GEOD-3254, E-GEOD-21837, E-GEOD-19445

RNAi
studied in E-GEOD-3697, E-MEXP-1857, E-MEXP-1315, E-MEXP-2759

Sample preparation
studied in E-GEOD-16728

sampleID
studied in E-GEOD-24283

Sampling time point
studied in E-GEOD-16797, E-GEOD-19743

Sex
studied in E-GEOD-2466, E-GEOD-7307

Stimulation
studied in E-GEOD-20114, E-GEOD-11428

Strain or line
studied in E-MEXP-1996

Subtype
studied in E-GEOD-24283

Survival time
studied in E-GEOD-3494, E-GEOD-19188

Test result
studied in E-TABM-276

Treatment
studied in E-GEOD-19246, E-GEOD-12198

Treatment code
studied in E-GEOD-20194, E-GEOD-16716

Treatments comments
studied in E-GEOD-20194, E-GEOD-16716

Tumor grading
studied in E-GEOD-4290

Processing time: 0.278 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM